UnitedHealth Group Incorporated $UNH Stock Position Raised by RDA Financial Network

RDA Financial Network lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 8.9% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 10,108 shares of the healthcare conglomerate’s stock after acquiring an additional 826 shares during the period. UnitedHealth Group accounts for about 0.9% of RDA Financial Network’s investment portfolio, making the stock its 24th largest position. RDA Financial Network’s holdings in UnitedHealth Group were worth $3,153,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in UNH. Brighton Jones LLC raised its stake in shares of UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after acquiring an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC grew its holdings in UnitedHealth Group by 137.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after buying an additional 2,324 shares during the last quarter. Polar Asset Management Partners Inc. acquired a new stake in UnitedHealth Group in the 4th quarter valued at approximately $1,973,000. Redwood Investment Management LLC grew its holdings in UnitedHealth Group by 73.1% in the 4th quarter. Redwood Investment Management LLC now owns 1,376 shares of the healthcare conglomerate’s stock valued at $696,000 after buying an additional 581 shares during the last quarter. Finally, Silvercrest Asset Management Group LLC grew its holdings in UnitedHealth Group by 47.8% in the 4th quarter. Silvercrest Asset Management Group LLC now owns 38,796 shares of the healthcare conglomerate’s stock valued at $19,625,000 after buying an additional 12,550 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $352.61 on Friday. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The company has a market capitalization of $319.35 billion, a PE ratio of 15.28, a price-to-earnings-growth ratio of 2.31 and a beta of 0.45. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73. The business has a 50 day simple moving average of $291.98 and a 200 day simple moving average of $369.01.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter in the previous year, the firm posted $6.80 EPS. The company’s revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be given a $2.21 dividend. The ex-dividend date is Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.5%. UnitedHealth Group’s payout ratio is presently 38.30%.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the company. Baird R W lowered UnitedHealth Group from a “hold” rating to a “strong sell” rating in a report on Thursday, July 31st. Oppenheimer decreased their price objective on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a report on Wednesday, July 30th. Bank of America lifted their price objective on UnitedHealth Group from $290.00 to $325.00 and gave the stock a “neutral” rating in a report on Monday, August 18th. Wall Street Zen lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Saturday, May 24th. Finally, HSBC reissued a “reduce” rating and set a $270.00 price objective (down previously from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. Sixteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average target price of $358.95.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.